Lite Strategy LITS
NASDAQ LITS
$0.99 +0.05 (+4.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Non-Current Assets (2011 - 2026)

Lite Strategy (LITS) posted quarterly Non-Current Assets of $46.8 million for Q1 2026, down 35.0% quarter-over-quarter from $72.0 million in Q4 2025.

Lite Strategy (LITS) Non-Current Assets (2011 - 2026) Analysis & Trends

Lite Strategy's Non-Current Assets history runs 16 years deep, the most recent figure standing at $46.8 million for Q1 2026.

  • In Q1 2026, Non-Current Assets changed N/A year-over-year to $46.8 million; the TTM figure through Mar 2026 stood at $218.9 million (up 35733.06% YoY), while the FY2024 annual figure was $606000.0, down 95.44% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $46.8 million, down from $72.0 million in the prior quarter.
  • The five-year high for Non-Current Assets was $100.1 million in Q3 2025, with the low at $5000.0 in Q3 2024.
  • The 5-year median for Non-Current Assets is $13.1 million (2023), against an average of $23.9 million.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Assets tumbled 99.96% in 2024, then surged 2001920.0% in 2025.
  • Lite Strategy's Non-Current Assets stood at $14.2 million in 2022, then retreated by 12.63% to $12.4 million in 2023, then plunged by 99.96% to $5000.0 in 2024, then soared by 1440400.0% to $72.0 million in 2025, then plunged by 35.0% to $46.8 million in 2026.
  • Business Quant data shows LITS's Non-Current Assets at $46.8 million in Q1 2026, $72.0 million in Q4 2025, and $100.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 14.88 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 23.28 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.15 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.96 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 938.60 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 468.65 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 18.06 Bn
10 Lite Strategy 35.71 Mn 28.17 Mn - 46.81 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 46.81 Mn
Dec 31, 2025 72.03 Mn
Sep 30, 2025 100.10 Mn
Sep 30, 2024 5,000.00
Jun 30, 2024 606,000.00
Mar 31, 2024 11.89 Mn
Dec 31, 2023 12.37 Mn
Sep 30, 2023 12.83 Mn
Jun 30, 2023 13.28 Mn
Mar 31, 2023 13.70 Mn
Dec 31, 2022 14.15 Mn
Sep 30, 2022 14.68 Mn
Jun 30, 2022 10.71 Mn
Mar 31, 2022 10.96 Mn
Dec 31, 2021 8.74 Mn
Sep 30, 2021 8.99 Mn
Jun 30, 2021 9.28 Mn
Mar 31, 2021 9.56 Mn
Dec 31, 2020 9.85 Mn
Sep 30, 2020 10.08 Mn